Aedes aegypti
Aedes aegypti, the yellow fever mosquito, is a mosquito that can spread dengue fever, chikungunya, Zika fever, Mayaro and yellow fever viruses, and other disease agents. The mosquito can be recognized by black and white markings on its legs and a marking in the form of a lyre on the upper surface of its thorax. This mosquito originated in Africa, but is now found in tropical, subtropical and temperate regions throughout the world. Biology. "Aedes aegypti" is a long, dark mosquito which can be recognized by white markings on its legs and a marking in the form of  a lyre on the upper surface of its thorax. Females are larger than males. Microscopically females possess small palps tipped with silver or white scales, and their antennae have sparse short hairs, whereas those of males are feathery. "Aedes aegypti" can be mixed up with "Aedes albopictus" without a magnifying glass: The latter have a white stripe on the top of the mid thorax. Males live off fruit and only the female bites for blood, which she needs to mature her eggs. To find a host, she is attracted to chemical compounds emitted by mammals, including ammonia carbon dioxide lactic  acid, and octenol. Scientists at The United States Department of Agriculture (USDA) Agricultural Research Service studied the specific chemical structure of octenol to better understand why this chemical attracts the mosquito to its host and found the mosquito has a preference for "right-handed" (dextrorotatory) octenol molecules. The preference for biting humans is dependent on expression of the odorant receptor "AaegOr4". The white eggs are laid separately into water and not together, unlike most other mosquitoes, and soon turn black. The larvae feed on bacteria, grow over a period of weeks until they reach the pupa stage. The lifespan of  an adult "Ae. aegypti" is two to four weeks depending on conditions, but the eggs can be viable for over a year in a dry state, which allows the mosquito to re-emerge after a cold winter or dry spell. Hosts. Mammalian hosts include domesticated horses, and feral and wild horses and equids more generally. As of 2009 birds were found to be the best food supply for "Ae. aegypti" among all taxa. Distribution. "Aedes aegypti" originated in Africa and was spread to the New World through slave trade, but is now found in tropical, subtropical and temperate regions throughout  the world. "Ae. aegypti"'s distribution has increased in the past two to three decades worldwide, and it is considered to be among the most widespread mosquito species. In 2016, Zika virus-capable mosquito populations have been found adapting for persistence in warm temperate climates. Such a population has been identified to exist in parts of Washington, DC, and genetic evidence suggests they survived at least the last four winters in the region. One of the study researchers noted, " ...some mosquito species are finding ways to survive in normally restrictive environments by taking advantage of underground refugia". As the world 's climate becomes warmer, the range of "Aedes aegypti" and a hardier species originating in Asia, the tiger mosquito "Aedes albopictus", which can expand its range to relatively cooler climates, will inexorably spread north and south. Sadie Ryan of the University of Florida was the lead author in a 2019 study published in "PLOS Neglected Tropical Diseases" that estimated the vulnerability of naïve populations in geographic regions that currently do not harbor vectors i.e., for Zika in the Old World. Ryan's co-author, Georgetown University's Colin Carlson remarked,"Plain and simple, climate change is going to kill a lot  of people." As of 2020, the Northern Territory Government Australia and the Darwin City Council have recommended tropical cities initiate rectification programs to rid their cities of potential mosquito breeding stormwater sumps. A 2019 study published in "Nature Microbiology" found that accelerating urbanization and human movement would also contribute to the spread of "Aedes" mosquitoes. Genomics. In 2007, the genome of "Aedes aegypti" was published, after it had been sequenced and analyzed by a consortium including scientists at The Institute for Genomic Research (now part of the J. Craig Venter Institute), the European Bioinformatics Institute, the Broad Institute, and the  University of Notre Dame. The effort in sequencing its DNA was intended to provide new avenues for research into insecticides and possible genetic modification to prevent the spread of virus. This was the second mosquito species to have its genome sequenced in full (the first was "Anopheles gambiae"). The published data included the 1.38 billion base pairs containing the insect's estimated 15,419 protein-encoding genes. The sequence indicates the species diverged from "Drosophila melanogaster" (the common fruit fly) about , and "Anopheles gambiae" and this species diverged about . Matthews "et al.", 2018 finds "A. aegypti" to carry a large and  diverse number of transposable elements. Their analysis suggests this is common to all mosquitoes. Vector of disease. "Aedes aegypti" is a vector for transmitting numerous pathogens. According to the Walter Reed Biosystematics Units as of 2022, it is associated with the following 54 viruses and 2 species of Plasmodium: Aino virus (AINOV), African horse sickness virus (AHSV), Bozo virus (BOZOV), Bussuquara virus (BSQV), Bunyamwera virus (BUNV), Catu virus (CATUV), Chikungunya virus (CHIKV), Chandipura vesiculovirus (CHPV), Cypovirus (unnamed), Cache Valley virus (CVV), Dengue virus (DENV), Eastern Equine Encephalitis virus (EEEV), Epizootic hemorrhagic disease virus (EHDV), Guaroa virus (GROV), Hart Park virus  (HPV), Ilheus virus (ILHV), Irituia virus (IRIV), Israel Turkey Meningoencephalitis virus (ITV), Japanaut virus (JAPV), Joinjakaka (JOIV), Japanese encephalitis virus (JBEV), Ketapang virus (KETV), Kunjin virus (KUNV), La Crosse virus (LACV), Mayaro virus (MAYV), Marburg virus (MBGV), Marco virus (MCOV), Melao virus (MELV) Marituba virus (MTBV), Mount Elgon bat virus (MEBV), Mucambo virus (MUCV), Murray Valley Encephalitis virus (MVEV), Navarro virus (NAVV), Nepuyo virus (NEPV), Nola virus (NOLV), Ntaya virus (NTAV), Oriboca virus (ORIV), Orungo virus (ORUV), Restan virus (RESV), Rift Valley fever virus (RVFV), Semliki Forest virus (SFV), Sindbis virus (SINV), Tahyna virus (TAHV), Tsuruse virus (TSUV), Tyuleniy virus  (TYUV), Venezuelan equine encephalitis virus (VEEV), Vesicular stomatitis virus (Indiana serotype), Warrego virus (WARV), West Nile virus (WNV), Wesselsbron virus (WSLV), Yaounde virus (YAOV) Yellow fever virus (YFV), Zegla virus (ZEGV), Zika virus, as well as Plasmodium gallinaceum and Plasmodium lophurae. This mosquito also mechanically transmits some veterinary diseases. In 1952 Fenner "et al.", found it transmitting the myxoma virus between rabbits and in 2001 Chihota "et al.", the lumpy skin disease virus between cattle. The yellow fever mosquito can contribute to the spread of reticular cell sarcoma among Syrian hamsters. Bite prevention methods. The Centers for Disease Control and  Prevention traveler's page on preventing dengue fever suggests using mosquito repellents that contain DEET (N, N-diethylmetatoluamide, 20% to 30%). It also suggests: Insect repellents containing DEET (particularly concentrated products) or "p"-menthane-3,8-diol (from lemon eucalyptus) were effective in repelling "Ae. aegypti" mosquitoes, while others were less effective or ineffective in a scientific study. The Centers for Disease Control and Prevention article on "Protection against Mosquitoes, Ticks, & Other Arthropods" notes that "Studies suggest that concentrations of DEET above approximately 50% do not offer a marked increase in protection time against mosquitoes; DEET efficacy tends to plateau at a concentration  of approximately 50%". Other insect repellents recommended by the CDC include Picaridin (KBR 3023/icaridin), IR3535, and 2-undecanone. Population control efforts. Insecticides. Pyrethroids are commonly used. This widespread use of pyrethroids and DDT has caused Knockdown resistance ("kdr") mutations. Almost no research has been done on the fitness implications. studies by Kumar "et al.", 2009 on deltamethrin in India, Plernsub "et al.", 2013 on permethrin in Thailand, by Jaramillo-O "et al.", 2014 on λ-cyhalothrin in Colombia, by Alvarez-Gonzalez "et al.", 2017 on deltamethrin in Venezuela, are all substantially confounded. As of 2019, understanding of selective pressure  under withdrawal of insecticide is hence limited. Genetic modification. "Ae. aegypti" has been genetically modified to suppress its own species in an approach similar to the sterile insect technique, thereby reducing the risk of disease. The mosquitoes, known as , were developed by Oxitec, a spinout of Oxford University. Field trials in the Cayman Islands, in Juazeiro Brazil by Carvalho "et al.", 2015, and in Panama by Neira "et al.", 2014 have shown that the OX513A mosquitoes reduced the target mosquito populations by more than 90%. This mosquito suppression effect is achieved by a self-limiting gene that prevents the offspring  from surviving. Male modified mosquitoes, which do not bite or spread disease, are released to mate with the pest females. Their offspring inherit the self-limiting gene and die before reaching adulthood—before they can reproduce or spread disease. The OX513A mosquitoes and their offspring also carry a fluorescent marker for simple monitoring. To produce more OX513A mosquitoes for control projects, the self-limiting gene is switched off (using the Tet-Off system) in the mosquito production facility using an antidote (the antibiotic tetracycline), allowing the mosquitoes to reproduce naturally. In the environment, the antidote is unavailable to rescue mosquito  reproduction, so the pest population is suppressed. The mosquito control effect is nontoxic and species-specific, as the OX513A mosquitoes are "Ae. aegypti" and only breed with "Ae. aegypti". The result of the self-limiting approach is that the released insects and their offspring die and do not persist in the environment. In Brazil, the modified mosquitoes were approved by the National Biosecurity Technical Commission for releases throughout the country. Insects were released into the wild populations of Brazil, Malaysia, and the Cayman Islands in 2012. In July 2015, the city of Piracicaba, São Paulo, started releasing the OX513A mosquitoes . In 2015, the UK House of Lords called on the government to support more work on genetically modified insects in the interest of global health. In 2016, the United States Food and Drug Administration granted preliminary approval for the use of modified mosquitoes to prevent the spread of the Zika virus. Another proposed method consists in using radiation to sterilize male larvae so that when they mate, they produce no progeny. Male mosquitoes do not bite or spread disease. Using CRISPR/Cas9 based genome editing to engineer the genome of "Aedes aegypti" genes like ECFP (enhanced cyan fluorescent protein), Nix  (male-determining factor gene), Aaeg-wtrw (Ae. aegypti water witch locus), Kmo (kynurenine 3-monoxygenase), loqs (loquacious), r2d2 (r2d2 protein), ku70 (ku heterodimer protein gene) and lig4 (ligase4) were targeted to modify the genome of "Aedes aegypti". The new mutant will become incapable of pathogen transmission or result in population control. Infection with Wolbachia. In 2016 research into the use of a bacterium called "Wolbachia" as a method of biocontrol was published showing that invasion of "Ae. aegypti" by the endosymbiotic bacteria allows mosquitos to be resistant to certain arboviruses such as dengue fever and Zika virus strains currently circulating . In 2017 Alphabet, Inc. started the Debug Project to infect males of this species with "Wolbachia" bacteria, interrupting the reproductive cycle of these animals. Taxonomy. The species was first named (as "Culex aegypti") in 1757 by Fredric Hasselquist in his treatise '. Hasselquist was provided with the names and descriptions by his mentor, Carl Linnaeus. This work was later translated into German and published in 1762 as '. Since the latter is an uncritical reproduction of the former, they are both considered to antedate the starting point for zoological nomenclature in 1758. Nonetheless, the name "Aedes aegypti" was frequently used, starting with  H. G. Dyar in 1920. To stabilise the nomenclature, a petition to the International Commission on Zoological Nomenclature was made by P. F. Mattingly, Alan Stone, and Kenneth L. Knight in 1962. It also transpired that, although the name "Aedes aegypti" was universally used for the yellow fever mosquito, Linnaeus had actually described a species now known as "Aedes" ("Ochlerotatus") "caspius". In 1964, the commission ruled in favour of the proposal, validating Linnaeus' name, and transferring it to the species for which it was in general use. The yellow fever mosquito belongs to the tribe Aedini of the dipteran family  Culicidae and to the genus "Aedes" and subgenus "Stegomyia". According to one recent analysis, the subgenus "Stegomyia" of the genus "Aedes" should be raised to the level of genus. The proposed name change has been ignored by most scientists; at least one scientific journal, the "Journal of Medical Entomology", has officially encouraged authors dealing with aedile mosquitoes to continue to use the traditional names, unless they have particular reasons for not doing so. The generic name comes from the Ancient Greek ἀηδής, "aēdēs", meaning "unpleasant" or "odious". Subspecies. Two subspecies are commonly recognized: This classification is complicated by the results  of Gloria-Soria "et al.", 2016. Although confirming the existence of these two major subspecies, Gloria-Sora "et al." finds greater worldwide diversity than previously recognized and a large number of distinct populations separated by various geographic factors.